Page last updated: 2024-08-22

4-nitroimidazole and Trichomonas Infections

4-nitroimidazole has been researched along with Trichomonas Infections in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	6 (100.00)	2.80

Authors

Authors	Studies
Alva-Murillo, N; Avila, EE; Ramírez-Ledesma, MG; Rodríguez, MC	1
Boyce, G; Edwards, J; Edwards, RJ; Parboo, M	1
McNeil, CJ; Muzny, CA; Williamson, JC	1
Augostini, P; Bradley, ELP; Raphael, BH; Secor, WE	1
Kissinger, P; Muzny, CA; Van Gerwen, OT	1
Bourla, LN; Camino, AF; Legendre, D; Muzny, CA; Van Gerwen, OT	1

Reviews

1 review(s) available for 4-nitroimidazole and Trichomonas Infections

Article	Year
Updates in trichomonas treatment including persistent infection and 5-nitroimidazole hypersensitivity. Current opinion in infectious diseases, 2020, Volume: 33, Issue:1 Topics: Antiprotozoal Agents; Dose-Response Relationship, Drug; Drug Hypersensitivity; Female; Humans; Male; Metronidazole; Nitroimidazoles; Recurrence; Sexually Transmitted Diseases; Trichomonas Infections; Trichomonas vaginalis	2020

Article

Year

Updates in trichomonas treatment including persistent infection and 5-nitroimidazole hypersensitivity.

Current opinion in infectious diseases, 2020, Volume: 33, Issue:1

Topics: Antiprotozoal Agents; Dose-Response Relationship, Drug; Drug Hypersensitivity; Female; Humans; Male; Metronidazole; Nitroimidazoles; Recurrence; Sexually Transmitted Diseases; Trichomonas Infections; Trichomonas vaginalis

2020

Other Studies

5 other study(ies) available for 4-nitroimidazole and Trichomonas Infections

Article	Year
The antimicrobial peptides LL-37, KR-20, FK-13 and KR-12 inhibit the growth of a sensitive and a metronidazole-resistant strain of Trichomonas vaginalis. Parasitology research, 2022, Volume: 121, Issue:12 Topics: Antimicrobial Peptides; Antiprotozoal Agents; Drug Resistance; Humans; Metronidazole; Trichomonas Infections; Trichomonas vaginalis	2022
Trichomoniasis refractory to 5-nitroimidazole therapy in Trinidad. Tropical doctor, 2023, Volume: 53, Issue:1 Topics: Female; Humans; Metronidazole; Trichomonas Infections; Trichomonas Vaginitis; Trinidad and Tobago	2023
Successful Treatment of Persistent 5-Nitroimidazole-Resistant Trichomoniasis With an Extended Course of Oral Secnidazole Plus Intravaginal Boric Acid. Sexually transmitted diseases, 2023, 04-01, Volume: 50, Issue:4 Topics: Female; Humans; Metronidazole; Tinidazole; Trichomonas Infections; Trichomonas Vaginitis	2023
In Vitro Testing of Trichomonas vaginalis Drug Susceptibility: Evaluation of Minimal Lethal Concentrations for Metronidazole and Tinidazole That Correspond With Treatment Failure. Sexually transmitted diseases, 2023, 06-01, Volume: 50, Issue:6 Topics: Drug Resistance; Female; Humans; In Vitro Techniques; Metronidazole; Pharmaceutical Preparations; Tinidazole; Treatment Failure; Trichomonas Infections; Trichomonas vaginalis; Trichomonas Vaginitis	2023
Management of Trichomoniasis in the Setting of 5-Nitroimidazole Hypersensitivity. Sexually transmitted diseases, 2021, 08-01, Volume: 48, Issue:8 Topics: Female; Humans; Metronidazole; Nitroimidazoles; Trichomonas Infections; Trichomonas vaginalis; Trichomonas Vaginitis	2021